Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: quidditch who wrote (3150)	6/2/1999 12:52:00 PM
From: Don Miller	of 10280

I appreciate the inquiry, but Peter's opinion is what you really need. BIMHO, those European trials were going on for some time and probably well prior to LLY/FTC issue. It certainly puts some heat on the US and Japanese Licenses, to move it or lose it. Who really owns the trade name Zyrtec, UCB? If UCB owns the rights have they protected US and Japanese licensor rights to use the name beyond the patent life or some other period? Could UBC still sell the rights to Zless-Zyrtec in the US? Personally I think it is about time to think about sueing FTC for imparing/impeding SEPR/LLY business for no legally substantial reason.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next